• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

边缘型人格障碍中与焦虑及苯丙胺激发试验相关的脑电图平均频率变化

Changes in EEG mean frequency associated with anxiety and with amphetamine challenge in BPD.

作者信息

Cornelius J R, Schulz S C, Brenner R P, Soloff P H, Ulrich R F

机构信息

Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, PA 15213.

出版信息

Biol Psychiatry. 1988 Sep;24(5):587-94. doi: 10.1016/0006-3223(88)90169-2.

DOI:10.1016/0006-3223(88)90169-2
PMID:3048424
Abstract

Recent authors have hypothesized that cerebral dysfunction, as reflected in an abnormal EEG, may play an important role in the behavioral symptoms of patients with borderline personality disorder (BPD). Spectral analysis and amphetamine challenge testing are two promising methods for probing the clinical symptomatology of this disorder. In this study, we evaluated the relationship between clinical symptoms and computerized EEG spectral analysis in BPD patients both before and after amphetamine challenge. We found that mean frequency values on spectral analysis consistently correlated with anxiety levels in our patients, but did not correlate with a wide variety of other important symptoms, such as depression or transient psychosis. This result, coupled with our previous negative findings concerning EEG abnormalities in patients with BPD, casts doubt on the etiological relationship of cerebral dysrhythmias to the behavioral pathology of this disorder, but raises interesting questions concerning the relationship of anxiety and mean frequency.

摘要

近期的研究者推测,脑电图异常所反映的大脑功能障碍,可能在边缘型人格障碍(BPD)患者的行为症状中起重要作用。频谱分析和苯丙胺激发试验是探究该障碍临床症状的两种有前景的方法。在本研究中,我们评估了BPD患者在苯丙胺激发前后临床症状与计算机化脑电图频谱分析之间的关系。我们发现,频谱分析中的平均频率值始终与患者的焦虑水平相关,但与多种其他重要症状,如抑郁或短暂性精神病无关。这一结果,再加上我们之前关于BPD患者脑电图异常的阴性发现,让人对脑节律异常与该障碍行为病理学之间的病因关系产生怀疑,但也引发了关于焦虑与平均频率关系的有趣问题。

相似文献

1
Changes in EEG mean frequency associated with anxiety and with amphetamine challenge in BPD.边缘型人格障碍中与焦虑及苯丙胺激发试验相关的脑电图平均频率变化
Biol Psychiatry. 1988 Sep;24(5):587-94. doi: 10.1016/0006-3223(88)90169-2.
2
EEG in borderline personality disorder.边缘型人格障碍中的脑电图
Biol Psychiatry. 1988 Oct;24(6):731-2. doi: 10.1016/0006-3223(88)90156-4.
3
Effects of carbamazepine on dexamethasone suppression and sleep electroencephalography in borderline personality disorder.卡马西平对边缘型人格障碍患者地塞米松抑制及睡眠脑电图的影响。
Neuropsychobiology. 2002;45(3):113-9. doi: 10.1159/000054948.
4
Relationship between clinical symptoms and EEG findings in borderline personality disorder.边缘型人格障碍的临床症状与脑电图结果之间的关系。
Jpn J Psychiatry Neurol. 1993 Mar;47(1):37-46. doi: 10.1111/j.1440-1819.1993.tb02027.x.
5
EEG-vigilance regulation in Borderline Personality Disorder.边缘型人格障碍的脑电图警觉性调节。
Int J Psychophysiol. 2019 May;139:10-17. doi: 10.1016/j.ijpsycho.2019.02.007. Epub 2019 Feb 20.
6
Recurrent suicide attempts in patients with depressive and anxiety disorders: the role of borderline personality traits.抑郁和焦虑障碍患者的复发性自杀尝试:边缘型人格特质的作用。
J Affect Disord. 2013 Oct;151(1):23-30. doi: 10.1016/j.jad.2013.02.038. Epub 2013 Apr 25.
7
Depressive response to physostigmine challenge in borderline personality disorder patients.边缘型人格障碍患者对毒扁豆碱激发试验的抑郁反应。
Neuropsychopharmacology. 1997 Oct;17(4):264-73. doi: 10.1016/S0893-133X(97)00051-1.
8
EEG sleep evaluation of depression in borderline patients.
Am J Psychiatry. 1984 Feb;141(2):182-6. doi: 10.1176/ajp.141.2.182.
9
Empathy and alexithymia in borderline personality disorder: clinical and laboratory measures.边缘型人格障碍中的同理心和述情障碍:临床和实验室测量。
J Pers Disord. 2012 Oct;26(5):660-75. doi: 10.1521/pedi.2012.26.5.660.
10
Amphetamine response in borderline patients.边缘型人格障碍患者对安非他明的反应。
Psychiatry Res. 1985 Jun;15(2):97-108. doi: 10.1016/0165-1781(85)90045-9.